Xiapex

DRUG6 trials

Sponsors

Pfizer, Endo Pharmaceuticals, Jeppe Lange, MD, Oslo University Hospital, University Hospital, Akershus

Conditions

Dupuytren ContractureDupuytren's ContractureDupuytrens Contracture

Phase 3

Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)

CompletedNCT01229436

PfizerDupuytren's Contracture

Start: 2010-12-31End: 2012-10-31Updated: 2014-03-17

Phase 4

Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture

Oslo University HospitalDupuytrens Contracture

Start: 2015-04-30End: 2021-01-31Target: 50Updated: 2015-06-19

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

CompletedNCT02647619

University Hospital, AkershusDupuytren Contracture

Start: 2013-10-31End: 2022-04-30Updated: 2022-04-26

Unknown Phase

Post Approval Commitment Study

CompletedNCT01444729

Endo PharmaceuticalsDupuytren's Contracture

Start: 2012-03-31End: 2015-11-30Updated: 2017-10-26

Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

CompletedNCT01538017

Jeppe Lange, MDDupuytrens Contracture

Start: 2012-02-29End: 2016-10-31Updated: 2016-10-04

Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

CompletedNCT03331926

Jeppe LangeDupuytren Contracture

Start: 2017-01-01End: 2019-12-31Updated: 2020-04-22